title: [Methotrexate treatment in severe chronic ocular graft versus host disease (GvHD)].
authors: Augenklinik, Universitätsspital Basel, Universität Basel, Schweiz.
authors: S
authors: S
authors: Sabti
authors: J P
authors: JP
authors: Halter
authors: M M
authors: MM
authors: Bosch
authors: D
authors: D
authors: Goldblum
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000209:etiology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D008727:Methotrexate